Suppr超能文献

发现一种基于喹啉的苯砜衍生物作为抗锥虫剂。

Discovery of a quinoline-based phenyl sulfone derivative as an antitrypanosomal agent.

作者信息

Zhang Huaisheng, Collins Jasmine, Nyamwihura Rogers, Ware Shelbi, Kaiser Marcel, Ogungbe Ifedayo Victor

机构信息

Department of Chemistry, Jackson State University, Jackson, MS 39217, USA.

Department of Medical Parasitology & Infection Biology, Swiss Tropical and Public Health Institute, 4051 Basel, Switzerland; University of Basel, Petersplatz 1, 4003 Basel, Switzerland.

出版信息

Bioorg Med Chem Lett. 2018 May 15;28(9):1647-1651. doi: 10.1016/j.bmcl.2018.03.039. Epub 2018 Mar 24.

Abstract

A series of natural products-based phenyl sulfone derivative and their property-based analogues were investigated as potential growth inhibitors of Trypanosoma brucei. Trypanosoma brucei is a kinetoplastid protozoan parasite that causes trypanosomiasis. In this work, we found that nopol- and quinoline-based phenyl sulfone derivative were the most active and selective for T. brucei, and they were not reactive towards the active thiol of T. brucei's cysteine protease rhodesain. A thiol reactive variant of the quinoline-based phenyl sulfone was subsequently investigated and found to be a moderate inhibitor of rhodesain. The quinoline-based compound that is not reactive towards rhodesain can serve a template for phenotypic-based lead discovery while its thiol-active congener can serve as template for structure-based investigation of new antitrypanosomal agents.

摘要

研究了一系列基于天然产物的苯砜衍生物及其基于性质的类似物作为布氏锥虫潜在生长抑制剂的情况。布氏锥虫是一种导致锥虫病的动质体原生动物寄生虫。在这项工作中,我们发现基于诺卜醇和喹啉的苯砜衍生物对布氏锥虫最具活性和选择性,并且它们对布氏锥虫半胱氨酸蛋白酶罗德西亚蛋白酶的活性硫醇没有反应性。随后研究了基于喹啉的苯砜的硫醇反应变体,发现它是罗德西亚蛋白酶的中度抑制剂。对罗德西亚蛋白酶无反应性的基于喹啉的化合物可作为基于表型的先导发现模板,而其硫醇活性类似物可作为基于结构的新型抗锥虫药物研究模板。

相似文献

1
Discovery of a quinoline-based phenyl sulfone derivative as an antitrypanosomal agent.
Bioorg Med Chem Lett. 2018 May 15;28(9):1647-1651. doi: 10.1016/j.bmcl.2018.03.039. Epub 2018 Mar 24.
2
Vinyl sulfone-based inhibitors of trypanosomal cysteine protease rhodesain with improved antitrypanosomal activities.
Bioorg Med Chem Lett. 2020 Jul 15;30(14):127217. doi: 10.1016/j.bmcl.2020.127217. Epub 2020 Apr 28.
3
Identification of non-peptidic cysteine reactive fragments as inhibitors of cysteine protease rhodesain.
Bioorg Med Chem Lett. 2015 Oct 15;25(20):4509-12. doi: 10.1016/j.bmcl.2015.08.074. Epub 2015 Sep 2.
4
Novel 4-[4-(4-methylpiperazin-1-yl)phenyl]-6-arylpyrimidine derivatives and their antitrypanosomal activities against T.brucei.
Bioorg Med Chem Lett. 2024 Sep 1;109:129825. doi: 10.1016/j.bmcl.2024.129825. Epub 2024 May 31.
5
Peptidyl Vinyl Ketone Irreversible Inhibitors of Rhodesain: Modifications of the P2 Fragment.
ChemMedChem. 2020 Aug 19;15(16):1552-1561. doi: 10.1002/cmdc.202000360. Epub 2020 Jul 7.
8
Exploring the Antiplasmodial 2-Aminopyridines as Potential Antitrypanosomal Agents.
ChemMedChem. 2019 Dec 17;14(24):2034-2041. doi: 10.1002/cmdc.201900492. Epub 2019 Nov 12.
9
Discovery and characterization of trypanocidal cysteine protease inhibitors from the 'malaria box'.
Eur J Med Chem. 2019 Oct 1;179:765-778. doi: 10.1016/j.ejmech.2019.06.062. Epub 2019 Jun 22.
10
Bistacrines as potential antitrypanosomal agents.
Bioorg Med Chem. 2017 Aug 15;25(16):4526-4531. doi: 10.1016/j.bmc.2017.06.051. Epub 2017 Jul 1.

引用本文的文献

1
Discovery of an orally active nitrothiophene-based antitrypanosomal agent.
Eur J Med Chem. 2024 Jan 5;263:115954. doi: 10.1016/j.ejmech.2023.115954. Epub 2023 Nov 15.
2
Covalent Inhibitors for Neglected Diseases: An Exploration of Novel Therapeutic Options.
Pharmaceuticals (Basel). 2023 Jul 19;16(7):1028. doi: 10.3390/ph16071028.
4
Two Tags in One Probe: Combining Fluorescence- and Biotin-based Detection of the Trypanosomal Cysteine Protease Rhodesain.
Chemistry. 2022 Nov 7;28(62):e202201636. doi: 10.1002/chem.202201636. Epub 2022 Sep 7.
5
A simple and convenient synthesis of 3-salicyloylquinoline-4-carboxylic esters from chromone and isatin.
RSC Adv. 2019 Nov 12;9(63):37057-37060. doi: 10.1039/c9ra08124k. eCollection 2019 Nov 11.
6
Phenotypic investigation of 4-nitrophenylacetyl- and 4-nitro-1-imidazoyl-based compounds as antileishmanial agents.
Parasitology. 2022 Apr;149(4):490-495. doi: 10.1017/S0031182021002079. Epub 2022 Feb 3.
7
Nopol-Based Quinoline Derivatives as Antiplasmodial Agents.
Molecules. 2021 Feb 14;26(4):1008. doi: 10.3390/molecules26041008.
8
and Evaluation of an Adamantyl-Based Phenyl Sulfonyl Acetamide against Cutaneous Leishmaniasis Models of .
Antimicrob Agents Chemother. 2020 Nov 17;64(12). doi: 10.1128/AAC.01188-20.
9
Vinyl sulfone-based inhibitors of trypanosomal cysteine protease rhodesain with improved antitrypanosomal activities.
Bioorg Med Chem Lett. 2020 Jul 15;30(14):127217. doi: 10.1016/j.bmcl.2020.127217. Epub 2020 Apr 28.

本文引用的文献

1
and Studies of the Trypanocidal Effect of Novel Quinolines.
Antimicrob Agents Chemother. 2018 Jan 25;62(2). doi: 10.1128/AAC.01936-17. Print 2018 Feb.
3
Synthesis of novel quinoline-based 4,5-dihydro-1H-pyrazoles as potential anticancer, antifungal, antibacterial and antiprotozoal agents.
Eur J Med Chem. 2017 May 5;131:237-254. doi: 10.1016/j.ejmech.2017.03.016. Epub 2017 Mar 16.
4
Congenital Trypanosomiasis in Child Born in France to African Mother.
Emerg Infect Dis. 2016 May;22(5):935-7. doi: 10.3201/eid2205.160133.
7
Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activity.
Eur J Med Chem. 2015 Nov 13;105:120-37. doi: 10.1016/j.ejmech.2015.10.007. Epub 2015 Oct 19.
8
The Oral Antimalarial Drug Tafenoquine Shows Activity against Trypanosoma brucei.
Antimicrob Agents Chemother. 2015 Oct;59(10):6151-60. doi: 10.1128/AAC.00879-15. Epub 2015 Jul 20.
9
Human African trypanosomiasis in the Democratic Republic of the Congo: disease distribution and risk.
Int J Health Geogr. 2015 Jun 6;14:20. doi: 10.1186/s12942-015-0013-9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验